Actively Recruiting
MRI Versus Ocular UltraSonography for a Non Contact Evaluation of Ocular Layers
Led by Fondation Ophtalmologique Adolphe de Rothschild · Updated on 2026-01-05
30
Participants Needed
1
Research Sites
144 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
D0: inclusion visit * information * Realization of the ocular ultrasound (care) * Collection of consent * Realization of high resolution MRI with injection of contrast product (duration of 30 minutes) For the realization of the MRI, the contrast product used is the gadobutrol. The dose, the lowest allowing an enhancement of sufficient contrast for diagnostic purposes (0.1 mmol/kg body mass body), is administered as a bolus intravenously in the lying patient. The MRI examination can begin immediately after injection. The patient should be monitored for at least half an hour after this, the majority of undesirable effects occurring at the during this period. The indication of ocular ultrasound and ophthalmological follow-up of the patient up to 1 month after inclusion will be collected at from their medical records.
CONDITIONS
Official Title
MRI Versus Ocular UltraSonography for a Non Contact Evaluation of Ocular Layers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient over 18 years old
- Referred for diagnostic eye ultrasound imaging
- Provides informed consent to participate
- Member of or beneficiary of a social security scheme
You will not qualify if you...
- Presence of absolute or relative contraindications to MRI such as pacemaker, neurosensory stimulator, implantable defibrillator, ferromagnetic ocular or brain foreign body, or claustrophobia
- Contraindications to gadolinium injection including allergy to contrast products, bronchial asthma, allergic conditions, or kidney failure with creatinine clearance below 30 mL/min
- Under legal protection measures
- Pregnant or breastfeeding women; pregnancy test required for women of childbearing age before inclusion
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hopital Fondation Adolphe de Rothschild
Paris, Paris, France, 75019
Actively Recruiting
Research Team
A
Amélie Yavchitz, PhD
CONTACT
Y
Yvonne PURCELL, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here